Clinical trial
Evaluation of the Serum Markers sFLt1 and PlGF for the Prediction of the Complications of the Placental Vascular Pathologies in the 3rd Quarter of the Pregnancy.
NCT03455387 is registered in ClinicalTrials.gov with Centre Hospitalier Metropole Savoie as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Serum Markers sFLt1 and PlGF for the Prediction of the Complications of the Placental Vascular Pathologies in the 3rd Quarter of the Pregnancy.
- Lead sponsor
- Centre Hospitalier Metropole Savoie
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 10, 2017
- Completion date
- December 31, 2019
- Enrollment
- 233 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
eclampsia, fetal death, fetal growth retardation, antenatal, hellp syndrome, placental abruption, pre-eclampsia